The new Booklet-Label is equipped with several security features which is especially relevant considering EU 2016/161 Falsified Medicine Directive.

Interphex: Innovative Security Label from Schreiner MediPharm in the Spotlight

In Europe, our Schreiner MediPharm business unit successfully premiered its new Booklet-Label with integrated closure seal and digital features at Pharmapack in Paris at the beginning of February.  Now, the U.S. market launch is coming up at Interphex in New York in mid-March. Our U.S. colleagues will be on site from March 21 to 23 at Booth 1153 where Schreiner MediPharm’s entire portfolio of customized Pharma Security solutions to protect the supply chain will be showcased.

Schreiner MediPharm’s newly developed Booklet-Label with diverse security features is especially relevant considering pending regulations such as EU 2016/161 Falsified Medicine Directive which, upon enactment in February 2019, will require innovative and reliable solutions to protect patients against falsified medicines.

The Security Booklet-Label’s bottom layer contains a tab serving as a closure seal for tampering protection. When the seal is opened, a void effect emerges as an irreversible first-opening indication. Applied to a medicine carton, the Booklet-Label allows a pharmacist, for example, to view the product information without opening the package or destroying the tamper protection. In addition, the label is equipped with three digital security features: The BitSecure copy detection pattern, the KeySecure tracing system as well as an integrated NFC chip for smart authentication.

For more information on Schreiner MediPharm, please visit www.schreiner-medipharm.com

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *

This post is also available in: German